NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

benzinga · June 6, 2026 · 1 min read

Clinically Reviewed by Editorial Advisory Panel

depression

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.

Originally reported by benzinga. Read more

Source: https://www.benzinga.com/pressreleases/26/06/g53025186/nrx-pharmaceuticals-nasdaq-nrxp-notes-presentation-by-osmind-inc-of-iv-ketamine-efficacy-vs-nasal-